Free Trial

IBEX (IBEX) 10K Form and Latest SEC Filings 2026

IBEX logo
$30.44 -0.58 (-1.87%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$30.52 +0.08 (+0.28%)
As of 05/13/2026 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest IBEX SEC Filings & Recent Activity

IBEX (NASDAQ:IBEX) has submitted 274+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in IBEX's financial statements. The most recent filing was a Form 8-K submitted on May 13, 2026.

Form 4
IBEX Ltd Reports Ownership Change on May. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
IBEX Files Current Report on May. 13, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
IBEX Files Annual Report on Sep. 11, 2025

The 10-K contains IBEX's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

IBEX SEC Filing History

Browse IBEX's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/13/2026 4:20 PM
IBEX (1720420) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2026 3:53 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 4:04 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 11:18 AM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2026 12:25 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2026 2:51 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 3:17 PM
IBEX (1720420) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2026 9:22 AM
AMERICAN CENTURY INVESTMENT MANAGEMENT INC (52388) Filed by
IBEX (1720420) Subject
Form SCHEDULE 13G
04/17/2026 6:57 PM
Ballou-Aares Daniella (1973685) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:06 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:07 PM
IBEX (1720420) Issuer
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:09 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:10 PM
Casteel Julie K (1974084) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:11 PM
Afdahl David Martin (1974087) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:13 PM
Greenwald Taylor C (1513723) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2026 4:57 PM
Darwal Michael Joseph (1973678) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 3:52 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 12:31 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2026 12:37 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 4:08 PM
IBEX (1720420) Issuer
Keen Shuja (1973681) Reporting
Form 3
Initial statement of beneficial ownership of securities  
02/19/2026 11:48 AM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144/A
02/19/2026 10:00 AM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2026 12:15 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 11:11 AM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2026 8:09 AM
Darwal Michael Joseph (1973678) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:10 AM
Greenwald Taylor C (1513723) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:12 AM
Afdahl David Martin (1974087) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:14 AM
IBEX (1720420) Issuer
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:15 AM
Casteel Julie K (1974084) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:06 AM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 8:08 AM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2026 6:27 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 3:16 PM
IBEX (1720420) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2026 4:15 PM
Darwal Michael Joseph (1973678) Reporting
IBEX (1720420) Issuer
Form 3/A
01/27/2026 3:23 PM
Darwal Michael Joseph (1973678) Reporting
IBEX (1720420) Issuer
Form 3
Initial statement of beneficial ownership of securities  
12/30/2025 5:55 PM
Ballou-Aares Daniella (1973685) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 3:37 PM
IBEX (1720420) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2025 3:18 PM
IBEX (1720420) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/10/2025 3:45 PM
IBEX (1720420) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2025 9:26 AM
IBEX (1720420) Filer
Form DEFA14A
12/01/2025 7:45 AM
IBEX (1720420) Filer
Form DEFA14A
The one number Musk can't hide in the S-1 (Ad)

When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requires more electricity than some small countries use in a year, and SEC rules require it be disclosed. When that figure goes public, every analyst on Wall Street will race to identify the supplier. One small company already has a $1.5 billion backlog - and Dylan Jovine has the name and ticker.tc pixel

See the stock the SpaceX S-1 filing is likely to expose
11/24/2025 11:12 AM
Ballou-Aares Daniella (1973685) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2025 4:10 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4/A
10/28/2025 4:16 PM
IBEX (1720420) Filer
Form ARS
10/28/2025 4:17 PM
IBEX (1720420) Filer
Form DEF 14A
10/15/2025 3:13 PM
IBEX (1720420) Issuer
Ringman Michael (2091792) Reporting
Form 3
Initial statement of beneficial ownership of securities  
10/02/2025 5:01 PM
Greenwald Taylor C (1513723) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 4:51 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 4:39 PM
IBEX (1720420) Subject
Inson Paul Joseph (1974089) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 4:29 PM
Casteel Julie K (1974084) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 4:16 PM
IBEX (1720420) Subject
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 3:21 PM
IBEX (1720420) Issuer
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 3:25 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 2:53 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2025 3:41 PM
Greenwald Taylor C (1513723) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2025 3:24 PM
Greenwald Taylor C (1513723) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 6:51 PM
Casteel Julie K (1974084) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 3:17 PM
Casteel Julie K (1974084) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2025 12:42 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:20 PM
IBEX (1720420) Issuer
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 12:27 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025 8:25 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2025 8:06 PM
IBEX (1720420) Subject
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2025 8:16 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2025 6:58 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 7:02 PM
Greenwald Taylor C (1513723) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 6:55 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 6:48 PM
Casteel Julie K (1974084) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 6:51 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 6:37 PM
Afdahl David Martin (1974087) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 6:40 PM
IBEX (1720420) Issuer
Trofimuk-O'Connor Christina Alice (1973684) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2025 6:30 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025 11:19 AM
IBEX (1720420) Subject
Inson Paul Joseph (1974089) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2025 3:19 PM
IBEX (1720420) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2025 3:21 PM
IBEX (1720420) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/22/2025 6:07 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2025 12:31 PM
IBEX (1720420) Subject
Inson Paul Joseph (1974089) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025 4:33 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:28 PM
IBEX (1720420) Issuer
Khaishgi Mohammedulla (1975279) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 4:59 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 10:39 AM
IBEX (1720420) Subject
Khaishgi Mohammedulla (1975279) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025 7:35 PM
IBEX (1720420) Issuer
Khaishgi Mohammedulla (1975279) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025 3:20 PM
Dechant Robert Thomas (1298255) Reporting
IBEX (1720420) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025 2:50 PM
IBEX (1720420) Subject
Khaishgi Mohammedulla (1975279) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2025 7:22 PM
IBEX (1720420) Issuer
McGinnis Patrick (2043520) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025 11:04 AM
IBEX (1720420) Subject
Khaishgi Mohammedulla (1975279) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2025 4:05 PM
IBEX (1720420) Issuer
Inson Paul Joseph (1974089) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025 4:15 PM
Dawson Bruce Neil (1973708) Reporting
IBEX (1720420) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

IBEX SEC Filings - Frequently Asked Questions

IBEX (IBEX) has submitted 274+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

IBEX's fiscal year ends on June 30. The company typically files its 10-K annual report by the end of August, covering the prior fiscal year's financial results. Key financial data from these reports is available on IBEX's financial statements page.

The most recent filing was a Form 8-K submitted on May 13, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:IBEX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners